{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:48:14Z","timestamp":1787064494968,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"European Commission 7th Framework Project Predict-IV","award":["202222"],"award-info":[{"award-number":["202222"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.tiv.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T12:17:53Z","timestamp":1402921073000},"page":"79-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PA","title":["Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatment"],"prefix":"10.1016","volume":"30","author":[{"given":"Davide","family":"Germano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Uteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Pognan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah-Dine","family":"Chibout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2014.05.009_b0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1989.03430010065032","article-title":"Effects of cyclosporine therapy on plasma lipoprotein levels","volume":"262","author":"Ballantyne","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.tiv.2014.05.009_b9000","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-3-642-66896-8_78","article-title":"Influence of drugs on bile acid excretion","author":"Barth","year":"1978","journal-title":"Arch. Toxicol. Suppl."},{"key":"10.1016\/j.tiv.2014.05.009_b0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2014.05.009_b0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01926230701196414","article-title":"Phospholipidosis in nonclinical toxicity studies","volume":"35","author":"Berridge","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2014.05.009_b0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/10937404.2010.483940","article-title":"Biokinetic modeling and in vitro\u2013in vivo extrapolations","volume":"13","author":"Blaauboer","year":"2010","journal-title":"J. Toxicol. Environ. Health, Part B"},{"key":"10.1016\/j.tiv.2014.05.009_b0025","first-page":"560","article-title":"Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats","volume":"24","author":"Blotnik","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.05.009_b0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-5793(93)80403-H","article-title":"Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane","volume":"333","author":"Bohme","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tiv.2014.05.009_b9010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1345\/aph.1A035","article-title":"Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors","volume":"36","author":"Bolesta","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tiv.2014.05.009_b0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2005.05.051","article-title":"MRP2 and 3 in health and disease","volume":"234","author":"Borst","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2014.05.009_b0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.tiv.2013.01.010","article-title":"In vitro biokinetics of chlorpromazine and the influence of different dose metrics on effect concentrations for cytotoxicity in Balb\/c 3T3, Caco-2 and HepaRG cell cultures","volume":"27","author":"Broeders","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.05.009_b0045","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/oby.2002.137","article-title":"Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected]","volume":"10","author":"Carey","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.tiv.2014.05.009_b9015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1476-5381.2010.00913.x","article-title":"Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1\/2","volume":"161","author":"Choi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0050","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.tiv.2012.06.012","article-title":"Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches","volume":"27","author":"Coecke","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.05.009_b0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1087057111427586","article-title":"High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay","volume":"17","author":"Donato","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.tiv.2014.05.009_b0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/bp00009a007","article-title":"Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration","volume":"7","author":"Dunn","year":"1991","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.tiv.2014.05.009_b0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000190214","article-title":"Hyperbilirubinemia in a renal transplant patient due to cyclosporin A therapy","volume":"76","author":"Ertorer","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.tiv.2014.05.009_b0070","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/toxsci\/kfi145","article-title":"Characterization of chemically induced hepatotoxicity in collagen sandwiches of rat hepatocytes","volume":"85","author":"Farkas","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2014.05.009_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2005.03.033","article-title":"Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?","volume":"70","author":"Feinstein","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b9020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425255.2012.644535","article-title":"Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders","volume":"8","author":"Finsterer","year":"2012","journal-title":"Expert. Opin. Drug Metab Toxicol."},{"key":"10.1016\/j.tiv.2014.05.009_b9025","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/pds.1804","article-title":"Case series of liver failure associated with rosiglitazone and pioglitazone","volume":"18","author":"Floyd","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf"},{"key":"10.1016\/j.tiv.2014.05.009_b0080","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/0192623312447542","article-title":"Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse","volume":"40","author":"Foster","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2014.05.009_b0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2014.05.009_b9030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.2042-7158.1985.tb04953.x","article-title":"Effect of phenobarbitone on the pharmacokinetics and tissue levels of amiodarone in the rat","volume":"37","author":"Fruncillo","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0090","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.etp.2007.01.004","article-title":"Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development","volume":"58","author":"Fujimura","year":"2007","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2014.05.009_b0095","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jat.1420","article-title":"In vitro assay for drug-induced hepatosteatosis using rat primary hepatocytes, a fluorescent lipid analog and gene expression analysis","volume":"29","author":"Fujimura","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2014.05.009_b0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/mol.59.3.627","article-title":"Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat","volume":"59","author":"Funk","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b9035","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/hep.510270316","article-title":"Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat","volume":"27","author":"Gardner","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2014.05.009_b0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.102.035014","article-title":"Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition","volume":"302","author":"Gerk","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2014.05.009_b9040","first-page":"965","article-title":"Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt","volume":"6","author":"Guan","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.tiv.2014.05.009_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","article-title":"General review on in vitro hepatocyte models and their applications","volume":"640","author":"Guguen-Guillouzo","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2014.05.009_b0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2014.05.009_b0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.taap.2008.01.036","article-title":"Gene expression profiling in rat liver treated with compounds inducing phospholipidosis","volume":"229","author":"Hirode","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1289\/ehp.845553","article-title":"Pulmonary and generalized lysosomal storage induced by amphiphilic drugs","volume":"55","author":"Hruban","year":"1984","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2014.05.009_b9045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.2042-7158.1988.tb05193.x","article-title":"The effect of metoclopramide on the absorption and pharmacology of chlorpromazine in the rat","volume":"40","author":"Imamura","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b9050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bdd.604","article-title":"Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B","volume":"29","author":"Ishizaki","year":"2008","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.tiv.2014.05.009_b0130","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine","volume":"321","author":"Kahan","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tiv.2014.05.009_b0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.510230519","article-title":"Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin\u2013Johnson syndrome","volume":"23","author":"Kartenbeck","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2014.05.009_b9055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmech.2004.11.009","article-title":"Synthesis, pharmacological activity and hydrolytic behavior of glyceride prodrugs of ibuprofen","volume":"40","author":"Khan","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tiv.2014.05.009_b0140","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1089\/ten.tec.2010.0012","article-title":"A comparative study of genome-wide transcriptional profiles of primary hepatocytes in collagen sandwich and monolayer cultures","volume":"16","author":"Kim","year":"2010","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.tiv.2014.05.009_b0145","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.103.063073","article-title":"Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats","volume":"309","author":"Kobayashi","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2014.05.009_b0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tiv.2014.05.009_b0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tiv.2009.09.018","article-title":"Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis","volume":"24","author":"Kuroda","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.05.009_b0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","article-title":"Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies","volume":"22","author":"Labbe","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b9060","first-page":"100","article-title":"Rosiglitazone quantification in rat plasma using high performance liquid chromatography with mass spectrometric detection and its application to pre-clinical pharmacokinetic studies","volume":"65","author":"Lakshmi","year":"2011","journal-title":"PDA. J. Pharm. Sci. Technol."},{"key":"10.1016\/j.tiv.2014.05.009_b0165","doi-asserted-by":"crossref","first-page":"C1764","DOI":"10.1152\/ajpcell.1994.266.6.C1764","article-title":"Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration","volume":"266","author":"LeCluyse","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tiv.2014.05.009_b9065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/0253-7613.66836","article-title":"Effect of centchroman coadministration on the pharmacokinetics of metformin in rats","volume":"42","author":"Lal","year":"2010","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.taap.2006.12.016","article-title":"Gene expression profiles of murine fatty liver induced by the administration of valproic acid","volume":"220","author":"Lee","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.taap.2007.09.014","article-title":"Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver","volume":"226","author":"Lee","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0046-8177(90)90076-H","article-title":"Histopathologic analysis of suspected amiodarone hepatotoxicity","volume":"21","author":"Lewis","year":"1990","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tiv.2014.05.009_b9070","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.1840020622","article-title":"Valproate-induced hepatic steatogenesis in rats","volume":"2","author":"Lewis","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2014.05.009_b9075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/03639040802623941","article-title":"Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats","volume":"35","author":"Li","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.tiv.2014.05.009_b0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0009-2797(02)00054-6","article-title":"Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors","volume":"142","author":"Lloyd","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2014.05.009_b9080","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/00912709922008533","article-title":"Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolites","volume":"39","author":"Loi","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","article-title":"The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes","volume":"51","author":"Mayerson","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.tiv.2014.05.009_b0195","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/adt.2009.0196","article-title":"Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content\/high-throughput microscopy and automated image analysis","volume":"7","author":"McDonough","year":"2009","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.tiv.2014.05.009_b0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/138620710790596736","article-title":"Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance","volume":"13","author":"McKim","year":"2010","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.tiv.2014.05.009_b9085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1572-0241.2001.03809.x","article-title":"Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus","volume":"96","author":"Menon","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tiv.2014.05.009_b0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0176-z","article-title":"Validation of an in vitro screen for phospholipidosis using a high-content biology platform","volume":"22","author":"Morelli","year":"2006","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2014.05.009_b0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00042737-199603000-00015","article-title":"Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation","volume":"8","author":"Myara","year":"1996","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tiv.2014.05.009_b9090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/10717540801952431","article-title":"Preparation and evaluation of fast dissolving ibuprofen-polyethylene glycol 6000 solid dispersions","volume":"15","author":"Newa","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.tiv.2014.05.009_b9095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/BF02774694","article-title":"Intrahepatic cholestasis and hyperbilirubinemia in ethynyl estradiol and chlorpromazine-treated rats","volume":"18","author":"Obata","year":"1983","journal-title":"Gastroenterol. Jpn."},{"key":"10.1016\/j.tiv.2014.05.009_b0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1163\/15693910260698348","article-title":"Effects of salicylate on the pharmacokinetics of valproic acid after oral administration of sodium valproate in rats","volume":"17","author":"Ohshiro","year":"2003","journal-title":"Biog. Amines"},{"key":"10.1016\/j.tiv.2014.05.009_b0220","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.3748\/wjg.v11.i34.5394","article-title":"Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report","volume":"11","author":"Oikawa","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tiv.2014.05.009_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(90)90055-R","article-title":"The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system","volume":"74","author":"Paine","year":"1990","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2014.05.009_b0230","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/0024-3205(79)90117-6","article-title":"Apparent maintenance of cytochrome P 450 by nicotinamide in primary cultures of rat hepatocytes","volume":"24","author":"Paine","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2014.05.009_b0235","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1124\/dmd.113.052415","article-title":"Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures","volume":"41","author":"Parmentier","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.05.009_b0240","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.271.5252.1126","article-title":"Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene","volume":"271","author":"Paulusma","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.tiv.2014.05.009_b0245","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/jm7015683","article-title":"Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)","volume":"51","author":"Pedersen","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2014.05.009_b9100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0016-5085(24)05145-X","article-title":"Amiodarone-associated phospholipidosis and fibrosis of the liver Light, immunohistochemical, and electron microscopic studies","volume":"86","author":"Poucell","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2014.05.009_b0250","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tiv.2014.05.009_b9105","first-page":"787","article-title":"Phenothiazine-induced cholestatic jaundice","volume":"6","author":"Regal","year":"1987","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.tiv.2014.05.009_b9110","first-page":"121","article-title":"Herb-drug interaction of Fucus vesiculosus extract and amiodarone in rats: A potential risk for reduced bioavailability of amiodarone in clinical practice","volume":"52C","author":"Rodrigues","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tiv.2014.05.009_b9115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hep.1840120114","article-title":"Inhibition of hepatocytary vesicular transport by cyclosporin A in the rat: relationship with cholestasis and hyperbilirubinemia","volume":"12","author":"Roman","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2014.05.009_b0255","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(78)90690-X","article-title":"Effects of chlorpromazine hydrochloride and its metabolites on Mg2+- and Na+, K+-ATPase activities of canalicular-enriched rat liver plasma membranes","volume":"74","author":"Samuels","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2014.05.009_b0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/15376510600860185","article-title":"Adaptation of an in vitro phospholipidosis assay to an automated image analysis system","volume":"17","author":"Schurdak","year":"2007","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.tiv.2014.05.009_b0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.tiv.2014.05.009_b0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00223481","article-title":"Amiodarone \u2013 an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine","volume":"76","author":"Shaikh","year":"1987","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.tiv.2014.05.009_b9120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0016-5085(87)91025-0","article-title":"Cyclosporin A-induced cholestasis. The mechanism in a rat model","volume":"93","author":"Stone","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2014.05.009_b0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/17425255.3.3.407","article-title":"Drug metabolite profiling and elucidation of drug-induced hepatotoxicity","volume":"3","author":"Tang","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2014.05.009_b0280","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1021\/es100045y","article-title":"Effects of solvents and dosing procedure on chemical toxicity in cell-based in vitro assays","volume":"44","author":"Tanneberger","year":"2010","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tiv.2014.05.009_b0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-5926-10-6","article-title":"Hepatic expression of multidrug resistance protein 2 in biliary atresia","volume":"10","author":"Terui","year":"2011","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.tiv.2014.05.009_b0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","article-title":"Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs","volume":"127","author":"Tolosa","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2014.05.009_b9125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kfi185","article-title":"Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2014.05.009_b0295","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cbi.2009.05.015","article-title":"Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies","volume":"181","author":"Tuschl","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2014.05.009_b0300","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.tiv.2011.05.026","article-title":"High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis","volume":"25","author":"van de Water","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.05.009_b9130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1358\/mf.2008.30.7.1233243","article-title":"Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats","volume":"30","author":"Varanasi","year":"2008","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2014.05.009_b0305","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tiv.2014.05.009_b9135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0016-5085(19)35013-9","article-title":"Prolonged hepatic dysfunction after clinical recovery from chlorpromazine jaundice","volume":"43","author":"Waitzkin","year":"1962","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2014.05.009_b0310","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd2423","article-title":"Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges","volume":"6","author":"Wilke","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tiv.2014.05.009_b9140","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.toxlet.2013.06.025","article-title":"Predict-IV project overview (EU grant 202222)-non animal-based toxicity profiling by integrating toxicodynamics and biokinetics","volume":"221S","author":"Wolf","year":"2013","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.tiv.2014.05.009_b0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cbi.2004.09.011","article-title":"Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential","volume":"150","author":"Xu","year":"2004","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2014.05.009_b0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2014.05.009_b0325","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00423-005-0564-5","article-title":"Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer","volume":"390","author":"Yamada","year":"2005","journal-title":"Langenbecks Arch. Surg."},{"key":"10.1016\/j.tiv.2014.05.009_b9145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2006.07.053","article-title":"In vitro and in vivo evaluation of medicinal carbon granules and tablet on the adsorption of acetaminophen","volume":"328","author":"Yamamoto","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2014.05.009_b9150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2220\/biomedres.32.357","article-title":"Effects of kale ingestion on pharmacokinetics of acetaminophen in rats","volume":"32","author":"Yamasaki","year":"2011","journal-title":"Biomed. Res."},{"key":"10.1016\/j.tiv.2014.05.009_b0330","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.102.044107","article-title":"Pharmacokinetics of 5 (and 6)-carboxy-2\u2032,7\u2032-dichlorofluorescein and its diacetate promoiety in the liver","volume":"304","author":"Zamek-Gliszczynski","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2014.05.009_b9155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchromb.2007.05.015","article-title":"Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection","volume":"856","author":"Zhang","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.tiv.2014.05.009_b0335","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0005-2736(86)90197-5","article-title":"Cyclosporin A and a diaziridine derivative inhibit the hepatocellular uptake of chocolate, phalloidin and rifampicin","volume":"855","author":"Ziegler","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2014.05.009_b9160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:26:15Z","timestamp":1746253575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233314000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0887233314000897"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2014.05.009","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatment","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}